Vital Farms’ (VITL) “Equal Weight” Rating Reiterated at Morgan Stanley

Morgan Stanley restated their equal weight rating on shares of Vital Farms (NASDAQ:VITL) in a report released on Friday, Marketbeat Ratings reports. They currently have a $24.00 price objective on the stock, down from their prior price objective of $45.00.

VITL has been the topic of a number of other research reports. DA Davidson set a $47.00 target price on Vital Farms and gave the company a “buy” rating in a report on Wednesday, December 17th. Telsey Advisory Group reissued an “outperform” rating and issued a $50.00 price objective on shares of Vital Farms in a research report on Tuesday, January 13th. Jefferies Financial Group restated a “buy” rating and issued a $52.00 price objective on shares of Vital Farms in a research note on Wednesday, December 17th. BMO Capital Markets cut their target price on shares of Vital Farms from $60.00 to $50.00 and set an “outperform” rating for the company in a research note on Thursday, December 18th. Finally, Mizuho decreased their price target on shares of Vital Farms from $53.00 to $48.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 26th. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Vital Farms presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.64.

Vital Farms Stock Performance

NASDAQ:VITL opened at $21.09 on Friday. The firm has a market capitalization of $944.83 million, a PE ratio of 14.65 and a beta of 1.14. Vital Farms has a 1 year low of $19.80 and a 1 year high of $53.13. The company has a current ratio of 2.16, a quick ratio of 1.61 and a debt-to-equity ratio of 0.01. The firm’s fifty day simple moving average is $28.60 and its 200 day simple moving average is $35.98.

Vital Farms (NASDAQ:VITL) last released its earnings results on Thursday, February 26th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). The firm had revenue of $213.55 million for the quarter, compared to analyst estimates of $212.83 million. Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The firm’s revenue was up 28.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.23 EPS. On average, sell-side analysts anticipate that Vital Farms will post 1.11 EPS for the current year.

Insider Transactions at Vital Farms

In other news, insider Matthew Ohayer sold 25,000 shares of Vital Farms stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $30.85, for a total transaction of $771,250.00. Following the sale, the insider directly owned 6,361,190 shares in the company, valued at approximately $196,242,711.50. The trade was a 0.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Russell Diez-Canseco sold 16,734 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the sale, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. The trade was a 2.51% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 66,734 shares of company stock valued at $2,092,227 over the last ninety days. 21.30% of the stock is owned by insiders.

Institutional Investors Weigh In On Vital Farms

A number of hedge funds have recently made changes to their positions in VITL. Wasatch Advisors LP lifted its holdings in Vital Farms by 80.2% during the 2nd quarter. Wasatch Advisors LP now owns 2,074,803 shares of the company’s stock worth $79,921,000 after buying an additional 923,507 shares in the last quarter. William Blair Investment Management LLC acquired a new position in shares of Vital Farms during the fourth quarter valued at $25,534,000. Balyasny Asset Management L.P. boosted its holdings in Vital Farms by 466.5% in the fourth quarter. Balyasny Asset Management L.P. now owns 503,894 shares of the company’s stock valued at $16,094,000 after acquiring an additional 641,394 shares during the last quarter. Marshall Wace LLP boosted its holdings in Vital Farms by 97.4% in the second quarter. Marshall Wace LLP now owns 1,234,008 shares of the company’s stock valued at $47,534,000 after acquiring an additional 608,723 shares during the last quarter. Finally, Divisadero Street Capital Management LP increased its position in Vital Farms by 131.7% in the third quarter. Divisadero Street Capital Management LP now owns 993,338 shares of the company’s stock worth $40,876,000 after purchasing an additional 564,711 shares during the period. Institutional investors and hedge funds own 98.59% of the company’s stock.

Vital Farms News Summary

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Q4 revenue growth and top‑line clarity — Revenue rose ~28.6% year‑over‑year and Q4 revenue came in essentially inline with expectations, showing continued demand and scale benefits. This supports the company’s growth story even though EPS missed. MarketBeat / Press Release
• Neutral Sentiment: Board leadership transition — Founder Matt O’Hayer stepped down as Executive Chair; CEO Russell Diez‑Canseco was named Executive Chair to maintain continuity. This reduces governance uncertainty short‑term but is unlikely to change fundamentals immediately. Business Wire
• Negative Sentiment: EPS miss and mixed guidance reaction — Q4 EPS of $0.35 missed the $0.38 consensus (revenues roughly inline). Several outlets highlight the profit shortfall and guidance interpretation that disappointed some investors, which directly pressured the stock. Zacks
• Negative Sentiment: Securities‑class investigation announced — The Rosen Law Firm has opened an investigation alleging Vital Farms may have provided materially misleading information to investors. Such filings often increase short‑term selling pressure and can raise legal risk and potential future costs. GlobeNewswire
• Negative Sentiment: Analyst revisions and target cuts — Multiple firms updated coverage: Benchmark downgraded to “hold,” Morgan Stanley trimmed its price target to $24 (from $45), and Telsey cut its target to $35 while keeping an outperform stance. These moves reduce near‑term upside expectations and can amplify selling. Benzinga

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.